Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 17, Issue 4, Pages 393-406
Publisher
Informa UK Limited
Online
2016-11-04
DOI
10.1080/14737175.2017.1257385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis
- (2016) Laure Peyro Saint Paul et al. Expert Opinion on Drug Metabolism & Toxicology
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
- (2016) Afsaneh Shirani et al. Neurotherapeutics
- Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity
- (2016) Erin E. Longbrake et al. JAMA Neurology
- Progressive multiple sclerosis
- (2015) Daniel Ontaneda et al. CURRENT OPINION IN NEUROLOGY
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Exploring the origins of grey matter damage in multiple sclerosis
- (2015) Massimiliano Calabrese et al. NATURE REVIEWS NEUROSCIENCE
- Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration
- (2015) Joshua C. Orack et al. Stem Cells Translational Medicine
- High doses of biotin in chronic progressive multiple sclerosis: A pilot study
- (2015) Frédéric Sedel et al. Multiple Sclerosis and Related Disorders
- Remyelination Therapy in Multiple Sclerosis
- (2015) Danielle E. Harlow et al. Frontiers in Neurology
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
- (2013) Alberto Gajofatto et al. DISEASE MARKERS
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
- (2013) M. Filippi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
- (2012) Patrick Vermersch et al. BMC Neurology
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
- (2012) Peter Connick et al. LANCET NEUROLOGY
- T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial
- (2012) Dimitrios Karussis et al. PLoS One
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Review: The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis
- (2011) H. Lassmann NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- PAW25 A single-centre, pilot, randomised controlled trial of recombinant human erythropoietin in primary progressive multiple sclerosis
- (2010) I. Karpha et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- New perspectives in the natural history of multiple sclerosis
- (2010) H. Tremlett et al. NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
- (2009) X. Montalban et al. Multiple Sclerosis Journal
- Azathioprine in Multiple Sclerosis
- (2008) Paolo Invernizz et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Responsiveness and predictive value of EDSS and MSFC in primary progressive MS
- (2008) J. J. Kragt et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started